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woronary calcium. Tande et al. (1) demonstrated that the
odified Diamond-Forrester (MDF) score accurately iden-
ifies asymptomatic patients with a high coronary calcium
core and thereby may serve as a useful and cost-effective
ool to determine appropriate use of calcium scoring. Elec-
ron beam computed tomography (EBCT) is of greatest
alue in patients with an intermediate to high MDF score
1). Schermund et al. (2) reported that high-sensitivity
-reactive protein (CRP) and coronary calcium do not seem
o show any association after adjusting for traditional risk
actors and body mass index in the general population. The
ame group of authors reported that approximately one of
ix subjects in the general population of the German Ruhr
rea is classified discordantly as “high-risk” by the Framing-
am algorithm or by coronary calcium score. The utilization
f CRP in conjunction with coronary calcium must be
efined. Finally, exciting data were provided by Schmid et
l. (3), who showed a statistically significant relationship
etween the extent of calcification of the aortic valve and
ystemic inflammation, especially in patients with a high
mount of calcification in the aortic valve and coronary
rtery. These data lend credence to the possibility that these
ay be manifestations of the same disease.
ultislice computed tomography (MSCT) for coronary
rtery disease (CAD). The diagnostic accuracy of EBCT
nd four-slice MSCT was found to be limited based on an
nalysis of 25 published studies involving 1,439 patients. In
ontrast, the potential of 16-slice MSCT was found to be
quivalent (4). Habert et al. (5) showed that coronary
ngiography with MSCT, but not the coronary calcium
core, can help reduce the number of catheter procedures for
he diagnosis of CAD by up to 35% in symptomatic patients
ith suspected CAD.
agnetic resonance imaging (MRI). There was an ex-
losion in the number of abstracts presented on this imaging
odality at the American College of Cardiology (ACC)
nnual Session Highlights of 2004. Insofar as anatomy of
he heart is concerned, MRI is useful in a wide variety of
iseases. A new technique called Dyn-3D can acquire a
ubstantial amount of information in a short period and
ence can be employed if time is limited (6).
The message that resonated loudly in the field of MRI
as the detection of viable myocardium and myocardial
erfusion. It was shown that MRI was as good as, if not
etter than, scintigraphy for detecting viable myocardium
nd myocardial perfusion (7–9).
Not finding a scar on contrast-enhanced MRI demon-
trates a high negative predictive value for inducible mono-wFrom the Mayo Clinic College of Medicine, Rochester, Minnesota.orphic ventricular tachycardia, justifying its use in the
valuation of patients who had sudden cardiac death (10).
ositron emission tomography (PET). The promise of
etecting viable myocardium and predicting functional re-
overy by PET was brought to fruition (11). However, the
redictive accuracy was similar to that of single-photon
mission computed tomography (SPECT). The beneficial
ffects of lipid lowering may require evaluation by PET, as
quarter of the patients presumed to be adequately treated
or lipid lowering by current guidelines had perfusion
bnormalities detected by PET and had poor outcomes
12).
uclear perfusion imaging. Some of the exciting data on
he use of nuclear perfusion imaging presented at this
eeting dealt with the epidemic of metabolic syndrome.
he role of nuclear perfusion studies as a screening test in
atients with diabetes mellitus, test for risk factor stratifi-
ation, and test to demonstrate the value of glucose lowering
n coronary circulation and myocardial ischemia was estab-
ished in presentations made by several groups of investiga-
ors (13,14). The prevalence of silent myocardial ischemia is
igh in patients with diabetes as compared with those
ithout diabetes (15). It is cost effective to use nuclear
echniques for screening asymptomatic patients with diabe-
es mellitus.
chocardiography. Highlights in the field of echocardiog-
aphy included validation of the role of myocardial contrast
chocardiography in the detection of viable myocardium,
easurement of blood volume, and detection of perfused
ersus nonperfused myocardium. These studies were further
roof that myocardial contrast echocardiography is coming
f age (16,17).
Application of myocardial strain and strain rate imaging
n heart failure, cardiac resynchronization therapy, and
ypertrophy of the myocardium, in conjunction with stress
chocardiography for accurate detection of viable myocar-
ium, were the subject of numerous presentations. The
ntire area of Doppler myocardial imaging continues to
how promise in diagnosis of cardiac muscle disease (18,19).
It is a predictor of mortality in patients with a normal
RS complex, raising the intriguing possibility that the
urrent Food and Drug Administration criteria for implan-
ation of biventricular pacemakers in patients with heart
ailure may undergo changes in the near future (20).
Doppler myocardial imaging was observed to have an
dge over brain natriuretic peptide in prognostication of
atients with heart failure. A comprehensive Doppler ex-
mination, which included measurement of the E/Ea ratio,
as the only significant predictor of prognosis in patients
ith heart failure in this study of 81 patients (21).
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ACC 2004 Annual Session Highlights July 21, 2004:25A–27AHand-carried ultrasound as an adjunct to physical exam-
nation for use by medical students and house staff was
ound to be superior to experienced cardiologists performing
cardiac physical examination (22). The era of stethoscope
ay be headed toward a sunset with the development of
ompact ultrasonic devices.
Three-dimensional echocardiography occupied a promi-
ent role among the abstracts presented at this meeting.
hree-dimensional echocardiography provides better quan-
itative information on left ventricular (LV) function and
alve regurgitation than two-dimensional echocardiography
23).
Intracardiac echocardiography is becoming the standard
f care when performing radiofrequency ablation procedures
24). Its role in percutaneous atrial septal defect closure and
eft atrial appendage occlusion was emphasized in presen-
ations (25).
Workflow in the echocardiography laboratory is im-
ensely important in these times of limited resources. New
ransducer technology demonstrated that one can do more
ith less: less time and more information (26).
Stress echocardiography continues to mature and has
ecome an established technique. Schinkel et al. (27) from
he Netherlands demonstrated that dobutamine stress echo-
ardiography had incremental prognostic value in predicting
ong-term prognosis over clinical variables and was compa-
able to dobutamine SPECT in a large number of consec-
tive patients undergoing both tests. Strain and strain rate
esponse to infusion of dobutamine are feasible markers of
iability as compared with wall motion alone (28).
The value of real-time, full-volume three-dimensional
chocardiography was investigated, and, in six consecutive
atients undergoing dobutamine stress echocardiography,
ulerwitz et al. (29) could demonstrate its feasibility, lead-
ng to provocative suggestion that all stress echocardiogra-
hy in the future could be performed using full-volume
hree-dimensional acquisition technique. The implications
f this on workflow and accuracy, if validated by larger
tudies, is enormous.
Diastolic function is best assessed by echocardiography
nd Doppler myocardial imaging. Incremental advances
resented at ACC 2004 included the finding that the
chocardiographic grade of diastolic function reflects ven-
ricular wall stress and stiffness, independent of LV hyper-
rophy and co-morbidities. This was demonstrated by Cau-
uro et al. (30) in 47 consecutive patients undergoing
imultaneous Doppler and catheter studies.
In a high-volume clinical laboratory, it is difficult to
btain all parameters, and more importantly, the incremen-
al utility of each of these depends on the ability to obtain
he measurements and interobserver variability. Mitral flow
elocity and tissue Doppler indexes were found to have the
ighest success in recording and also had the lowest vari-
bility, leading Khan et al. (31) to conclude that these were
he most practical measures to obtain when performing
oppler studies for diastolic function.Finally, the role of transesophageal echocardiography
TEE) as the modality of choice for imaging atherosclerosis
f the aorta and left atrial appendage was reinforced during
poster session on TEE. Demonstration that atherosclero-
is of the aorta is not independently associated with LV
iastolic function and the role of TEE in follow-up of
atients with transcatheter occlusion of left atrial appendage
ere shown during this session (32,33).
What did ACC 2004 tell us? Noninvasive imaging is in
ts infancy. There is robust growth in the field of noninva-
ive imaging. Some of the modalities compete and, in many
nstances, play a complementary role. The field remains
ibrant and healthy, thus poised for growth.
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ayo Medical School, 200 First Street SW, Rochester, Minnesota
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